R & D

Research & Development Overview

R&D at ACI USA Healthcare operates through a structured, data-driven development framework aligned with ICH Q8, Q9, and Q10, ensuring robust formulation design, controlled processes, and globally compliant pharmaceutical products.

Our R&D ecosystem integrates multiple specialized functions into a unified development platform:

Formulation Development – Designing stable and effective pharmaceutical formulations

Analytical Development – Developing and validating analytical methods for product quality evaluation

Packaging & Labelling Development – Ensuring product protection, compliance, and usability

R&D Quality Assurance – Maintaining scientific integrity and regulatory alignment throughout development

All development activities are supported by Quality by Design (QbD) principles, structured experimentation, and comprehensive knowledge management.

Core R&D Practices

QbD-enabled formulation and process understanding
Risk assessment and mitigation throughout the development lifecycle
Analytical method development and lifecycle management
Material and component qualification based on performance and compatibility
Technology transfer supported by documented process knowledge
Stability evaluation driven by ICH climatic zone requirements

This approach ensures that products entering commercialization have clear process control strategies, defined critical parameters, and evidence-based performance reliability — supporting long-term supply assurance and global regulatory acceptance.